Tianjin Chase Sun Pharmaceutical Co.,Ltd

SZSE:300026 Rapporto sulle azioni

Cap. di mercato: CN¥10.2b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Tianjin Chase Sun PharmaceuticalLtd Gestione

Gestione criteri di controllo 3/4

Tianjin Chase Sun PharmaceuticalLtd's CEO is Dan Zheng, appointed in Mar 2017, has a tenure of 7.42 years. directly owns 0.05% of the company’s shares, worth CN¥5.03M. The average tenure of the management team and the board of directors is 7.4 years and 5 years respectively.

Informazioni chiave

Dan Zheng

Amministratore delegato

CN¥2.6m

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO7.4yrs
Proprietà del CEO0.05%
Durata media del management7.4yrs
Durata media del Consiglio di amministrazione5yrs

Aggiornamenti recenti sulla gestione

Recent updates

These 4 Measures Indicate That Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Is Using Debt Reasonably Well

Aug 02
These 4 Measures Indicate That Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Is Using Debt Reasonably Well

There's No Escaping Tianjin Chase Sun Pharmaceutical Co.,Ltd's (SZSE:300026) Muted Earnings

Jun 12
There's No Escaping Tianjin Chase Sun Pharmaceutical Co.,Ltd's (SZSE:300026) Muted Earnings

Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Has Announced A Dividend Of CN¥0.03

May 22
Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Has Announced A Dividend Of CN¥0.03

This Broker Just Slashed Their Tianjin Chase Sun Pharmaceutical Co.,Ltd (SZSE:300026) Earnings Forecasts

May 21
This Broker Just Slashed Their Tianjin Chase Sun Pharmaceutical Co.,Ltd (SZSE:300026) Earnings Forecasts

Tianjin Chase Sun PharmaceuticalLtd's (SZSE:300026) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 04
Tianjin Chase Sun PharmaceuticalLtd's (SZSE:300026) Sluggish Earnings Might Be Just The Beginning Of Its Problems

AMMINISTRATORE DELEGATO

Dan Zheng (60 yo)

7.4yrs

Mandato

CN¥2,608,700

Compensazione

Ms. Dan Zheng serves as General Manager of Tianjin Chase Sun Pharmaceutical Co.,Ltd since March 24, 2017 and serves as its Vice Chairman since April 24, 2019. She serves as Director of Tianjin Chase Sun Ph...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Dan Zheng
GM & Vice Chairman7.4yrsCN¥2.61m0.050%
CN¥ 5.0m
Wu Jun Lan
Executive GM12.7yrsCN¥1.81m0.050%
CN¥ 5.0m
Wu Sun
Deputy GMno dataCN¥979.30kNessun dato
Chun Xu Li
Deputy GMno dataCN¥1.11m0.022%
CN¥ 2.3m
Rui Qiang Chen
GM of Human Resource Center & Deputy GMno dataCN¥1.21m0.023%
CN¥ 2.3m
Kun Zhang
Deputy General Manager7.4yrsCN¥1.32m0.031%
CN¥ 3.1m
Xiao Zhong Lu
Deputy General Manager2.3yrsCN¥1.76mNessun dato

7.4yrs

Durata media

49yo

Età media

Gestione esperta: 300026's management team is seasoned and experienced (7.4 years average tenure).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Dan Zheng
GM & Vice Chairman7.3yrsCN¥2.61m0.050%
CN¥ 5.0m
Wu Jun Lan
Executive GM5.3yrsCN¥1.81m0.050%
CN¥ 5.0m
Wu Sun
Deputy GM5.3yrsCN¥979.30kNessun dato
Chun Xu Li
Deputy GMless than a yearCN¥1.11m0.022%
CN¥ 2.3m
Xiaoqing Yao
Chairman23.9yrsCN¥2.66m10.24%
CN¥ 1.0b
Peng Fei Tu
Independent Director4.6yrsCN¥120.00kNessun dato
Dan Liang
Employee Representative Member of Supervisory Board & Securities Affairs Representative11.3yrsCN¥91.00kNessun dato
Shengtian Wang
Independent Director6.7yrsCN¥120.00kNessun dato
Tao Gong
Independent Director4.6yrsCN¥120.00kNessun dato
Li Li
Independent Director3.8yrsCN¥120.00kNessun dato
Sen Lin
Directorless than a yearNessun datoNessun dato
Juan Chen
Director1.1yrsNessun datoNessun dato

5.0yrs

Durata media

55yo

Età media

Consiglio di amministrazione esperto: 300026's board of directors are considered experienced (5 years average tenure).